Zelluna ASA
Developing off-the-shelf TCR-NK cell therapies to treat patients with solid cancers.
ULTI | OL
Overview
Corporate Details
- ISIN(s):
- NO0010851603
- LEI:
- 254900B4VALJZR9TL744
- Country:
- Norway
- Address:
- Ullernchausseen 64, 0379 Oslo
- Website:
- https://www.zelluna.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Zelluna ASA is a clinical-stage biopharmaceutical company focused on developing treatments for solid cancers. The company is pioneering a proprietary, allogeneic T-cell receptor-based Natural Killer (TCR-NK) cell therapy platform. This "off-the-shelf" approach merges the targeting capabilities of T-cell receptors with the therapeutic functions of NK cells to address significant unmet medical needs in oncology. Zelluna's mission is to deliver transformative, safe, and cost-efficient therapies with the potential to cure patients with advanced solid tumors.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-10-09 07:58 |
Legal Proceedings Report
Zelluna Receives Positive MHRA Feedback and Strengthens UK Clinical Strategy fo…
|
English | 5.2 KB | ||
| 2025-09-10 08:00 |
Regulatory News Service
Zelluna Announces Investor Forum on Science & Strategy to be held on Wednesday …
|
English | 3.6 KB | ||
| 2025-08-20 07:00 |
Investor Presentation
Zelluna ASA Reports Second Quarter 2025 Financial Results and Provides General …
|
English | 1.0 MB | ||
| 2025-08-20 07:00 |
Investor Presentation
Zelluna ASA Reports Second Quarter 2025 Financial Results and Provides General …
|
English | 801.4 KB | ||
| 2025-08-20 07:00 |
Earnings Release
Zelluna ASA Reports Second Quarter 2025 Financial Results and Provides General …
|
English | 5.6 KB | ||
| 2025-08-14 12:00 |
Report Publication Announcement
Zelluna ASA: Invitation to Second Quarter 2025 results webcast presentation
|
English | 1.7 KB | ||
| 2025-07-03 12:07 |
Share Issue/Capital Change
Zelluna ASA - Grant of Share Options under Long-Term Incentive Program
|
English | 3.4 KB | ||
| 2025-06-25 16:19 |
Major Shareholding Notification
Disclosure of share transfer from Inven2 AS
|
English | 711 bytes | ||
| 2025-05-27 13:51 |
Major Shareholding Notification
Disclosure of Shareholding - Gjelsten Holding AS
|
English | 1.2 KB | ||
| 2025-05-27 13:38 |
Share Issue/Capital Change
ZLNA - New registered share capital
|
English | 1.9 KB | ||
| 2025-05-24 06:37 |
Share Issue/Capital Change
ZLNA - Issuance of shares through set-off of option exercise fee
|
English | 2.3 KB | ||
| 2025-05-08 05:00 |
Investor Presentation
Zelluna ASA Reports First Quarter 2025 Financial Results and Provides General B…
|
English | 1.3 MB | ||
| 2025-05-08 05:00 |
Quarterly Report
Zelluna ASA Reports First Quarter 2025 Financial Results and Provides General B…
|
English | 664.4 KB | ||
| 2025-05-08 05:00 |
Earnings Release
Zelluna ASA Reports First Quarter 2025 Financial Results and Provides General B…
|
English | 6.5 KB | ||
| 2025-04-30 06:00 |
Report Publication Announcement
Zelluna ASA: Invitation to First Quarter 2025 results webcast presentation
|
English | 1.7 KB |
Automate Your Workflow. Get a real-time feed of all Zelluna ASA filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Zelluna ASA
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Zelluna ASA via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
